GSK3B and colorectal cancer: Our study revealed that the levels of both MIF and SLC3A2 expression were increased in SW480 and SW620 cells, and a downregulation of those expression levels inhibited colorectal cancer cell proliferation, promoted cell iron death, inhibited cell migration and the EMT process, and affected the AKT/GSK‐3β signalling pathway.